Sfoglia per Autore
A comparative QSAR analysis of acetylcholinesterase inhibitors currently studied for the treatment of Alzheimer's disease
1997 Recanatini M.; Cavalli A.; Hansch C.
Comparative molecular field analysis of non-steroidal aromatase inhibitors: An extended model for two different structural classes
1998 Recanatini M.; Cavalli A.
WB 4101-related compounds. 2. Role of the ethylene chain separating amine and phenoxy units on the affinity for α1-adrenoreceptor subtypes and 5-HT(1A) receptors
1999 Bolognesi M.L.; Budriesi R.; Cavalli A.; Chiarini A.; Gotti R.; Leonardi A.; Minarini A.; Poggesi E.; Recanatini M.; Rosini M.; Tumiatti V.; Melchiorre C.
Linking CoMFA and protein homology models of enzyme-inhibitor interactions: An application to non-steroidal aromatase inhibitors
2000 Cavalli A.; Greco G.; Novellino E.; Recanatini M.
SAR of 9-amino-1,2,3-4-tetrahydroacridine-based acetylcholinesterase inhibitors: Synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues
2000 Recanatini M.; Cavalli A.; Belluti F.; Piazzi L.; Rampa A.; Bisi A.; Gobbi S.; Valenti P.; Andrisano V.; Bartolini M.; Cavrini V.
Acetylcholinesterase inhibitors for potential use in Alzheimer's disease: Molecular modeling, synthesis and kinetic evaluation of 11H-indeno-[1,2-b]-quinolin-10-ylamine derivatives
2000 Rampa A.; Bisi A.; Belluti F.; Gobbi S.; Valenti P.; Andrisano V.; Cavrini V.; Cavalli A.; Recanatini M.
Three-dimensional model of the cyclin-dependent kinase 1 (CDK1): Ab initio active site parameters for molecular dynamics studies of CDKs
2001 Cavalli A.; Dezi C.; Folkers G.; Scapozza L.; Recanatini M.
A new class of nonsteroidal aromatase inhibitors: Design and synthesis of chromone and xanthone derivatives and inhibition of the P450 enzymes aromatase and 17α-hydroxylase/C17,20-lyase
2001 Recanatini M.; Hartmann R.W.; Bisi A.; Cavalli A.; Belluti F.; Gobbi S.; Rampa A.; Valenti P.; Palzer M.; Palusczak A.
Acetylcholinesterase inhibitors: SAR and kinetic studies on ω-[N-methyl-N-(3-alkylcarbamoyloxyphenyl]methyl] aminoalkoxyaryl derivatives
2001 Rampa A.; Piazzi L.; Belluti F.; Gobbi S.; Bisi A.; Bartolini M.; Andrisano V.; Cavrini V.; Cavalli A.; Recanatini M.; Valenti P.
Looking for selectivity among cytochrome P450s inhibitors
2002 Cavalli A.; Recanatini M.
Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: An overview
2002 De Ponti F.; Poluzzi E.; Cavalli A.; Recanatini M.; Montanaro N.
Toward a pharmacophore for drugs inducing the long QT syndrome: Insights from a CoMFA study of HERG K+ channel blockers
2002 Cavalli A.; Poluzzi E.; De Ponti F.; Recanatini M.
Acetylcholinesterase inhibitors in the context of therapeutic strategies to combat alzheimer's disease
2002 Recanatini M.; Cavalli A.
Nonsteroidal aromatase inhibitors: Recent advances
2002 Recanatini M.; Cavalli A.; Valenti P.
Density functional study of the enzymatic reaction catalyzed by a cyclin-dependent kinase
2003 Cavalli A.; De Vivo M.; Recanatini M.
3-(4-{[benzyl(methyl)amino]methyl}-phenyl)-6,7-dimethoxy-2H-2-chromenone (AP2238) inhibits both acetylcholinesterase and acetylcholinesterase-induced β-amyloid aggregation: A dual function lead for Alzheimer's disease therapy
2003 Piazzi L.; Rampa A.; Bisi A.; Gobbi S.; Belluti F.; Cavalli A.; Bartolini M.; Andrisano V.; Valenti P.; Recanatini M.
Memoquin: a new compound to attack Alzheimer's disease drug discovery
2004 Cavalli A.; Bolognesi M.L.; Bartolini M.; Andrisano V.; Melchiorre C.; Recanatini M.; Capsoni S.; Cattaneo A.
In silico antitarget screening
2004 Recanatini M.; Bottegoni G.; Cavalli A.
A Computational Study of the Binding of Propidium to the Peripheral Anionic Site of Human Acetylcholinesterase
2004 CAVALLI A.; BOTTEGONI G.; RACO C.; DE VIVO M.; RECANATINI M.
Memoquin: a new therapeutic poly-agent for Alzheimer's disease
2004 Cavalli A.; Bolognesi M.L.; Bartolini M.; Andrisano V.; Melchiorre C.; Recanatini M.; Margotti E.; Capsoni S.; Cattaneo A.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile